找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Creating R&D Incentives for Medicines for Neglected Diseases; An Economic Analysis Frank Müller-Langer Book 2009 Gabler Verlag | Springer F

[复制链接]
查看: 16939|回复: 38
发表于 2025-3-21 16:05:34 | 显示全部楼层 |阅读模式
书目名称Creating R&D Incentives for Medicines for Neglected Diseases
副标题An Economic Analysis
编辑Frank Müller-Langer
视频video
丛书名称Ökonomische Analyse des Rechts
图书封面Titlebook: Creating R&D Incentives for Medicines for Neglected Diseases; An Economic Analysis Frank Müller-Langer Book 2009 Gabler Verlag | Springer F
描述This book is the revised version of a doctoral thesis written at the Graduiertenkolleg Law and Economics at Hamburg University. It addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of access to affordable medicines in poor countries. Tropical diseases, such as malaria or leishmaniasis, are among the main causes of death and disability in developing countries. Medical scholars have since long argued that medicines for those neglected infectious diseases either do not exist at all or badly need improvement. This neglect has two main reasons. First, tropical diseases virtually do not occur in the rich countries of the Northern Hemisphere where the bulk of new pharmaceutical inventions are made. Second, intellectual property protection in poor countries of the Southern Hemisphere, i. e. patents or copyrights, is often poorly developed. The innovator faces the risk of losing research and development (R&D) costs as imitators can offer generic drugs at marginal costs. Therefore, not much research is targeted at developing medicines for tropical diseases as the expected market returns from R&D in the private pharmaceuticals sector are too low
出版日期Book 2009
关键词Forschung & Entwicklung; Forschung und Entwicklung; Innovation; Medicines; Patente; Patents; R&D
版次1
doihttps://doi.org/10.1007/978-3-8349-8323-7
isbn_softcover978-3-8349-1730-0
isbn_ebook978-3-8349-8323-7
copyrightGabler Verlag | Springer Fachmedien Wiesbaden GmbH, Wiesbaden 2009
The information of publication is updating

书目名称Creating R&D Incentives for Medicines for Neglected Diseases影响因子(影响力)




书目名称Creating R&D Incentives for Medicines for Neglected Diseases影响因子(影响力)学科排名




书目名称Creating R&D Incentives for Medicines for Neglected Diseases网络公开度




书目名称Creating R&D Incentives for Medicines for Neglected Diseases网络公开度学科排名




书目名称Creating R&D Incentives for Medicines for Neglected Diseases被引频次




书目名称Creating R&D Incentives for Medicines for Neglected Diseases被引频次学科排名




书目名称Creating R&D Incentives for Medicines for Neglected Diseases年度引用




书目名称Creating R&D Incentives for Medicines for Neglected Diseases年度引用学科排名




书目名称Creating R&D Incentives for Medicines for Neglected Diseases读者反馈




书目名称Creating R&D Incentives for Medicines for Neglected Diseases读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:40:52 | 显示全部楼层
发表于 2025-3-22 02:55:32 | 显示全部楼层
Legal and Economic Analysis of Parallel Imports,duct faces potential competition from parallel imports by a foreign exclusive distributor. The model suggests that parallel imports will never occur in the sub-game perfect Nash equilibrium, as it will always be beneficial for the manufacturer to monopolize the home country by undercutting the price
发表于 2025-3-22 06:16:49 | 显示全部楼层
Solutions for the Problem of Underinvestment in R&D for Medicines for Neglected Infectious and Tropinfectious and tropical diseases. Furthermore, even if patent protection provided an adequate incentive mechanism to successfully stimulate R&D, there would still remain the problem that patented medicines may not be affordable for large groups of consumers in poor countries.
发表于 2025-3-22 10:24:57 | 显示全部楼层
https://doi.org/10.1007/978-3-8349-8323-7Forschung & Entwicklung; Forschung und Entwicklung; Innovation; Medicines; Patente; Patents; R&D
发表于 2025-3-22 16:33:01 | 显示全部楼层
978-3-8349-1730-0Gabler Verlag | Springer Fachmedien Wiesbaden GmbH, Wiesbaden 2009
发表于 2025-3-22 17:50:00 | 显示全部楼层
The TRIPS Agreement and Access to Patented Medicines, intellectual property (IP). In particular, the TRIPS Agreement is a result of the negotiations of the Uruguay Round (1986-1994), which finalized the General Agreement on Tariffs and Trade (GATT) by creating the World Trade Organization (WTO) on January 1, 1995.
发表于 2025-3-23 00:50:03 | 显示全部楼层
发表于 2025-3-23 01:35:13 | 显示全部楼层
发表于 2025-3-23 05:50:40 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-27 14:42
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表